FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377159003: Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3676208017 Abacavir 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3676210015 Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1202474017 Abacavir sulfate + lamivudine + zidovudine 300mg/150mg/300mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1207701015 Abacavir sulphate + lamivudine + zidovudine 300mg/150mg/300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1208512016 Abacavir sulfate + lamivudine + zidovudine 300mg/150mg/300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1478535013 Abacavir sulfate+lamivudine+zidovudine 300mg/150mg/300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2476796019 Abacavir 300mg/lamivudine 150mg/zidovudine 300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3490388012 Product containing abacavir sulfate 300 mg and lamivudine 150 mg and zidovudine 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494161015 Product containing abacavir sulfate 300 mg and lamivudine 150 mg and zidovudine 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3501587016 Abacavir sulfate 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569109018 Product containing only abacavir sulfate 300 mg and lamivudine 150 mg and zidovudine 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3569110011 Product containing only abacavir sulfate 300 mg and lamivudine 150 mg and zidovudine 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3676208017 Abacavir 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3676209013 Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3676210015 Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Product containing lamivudine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Product containing zidovudine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Lamivudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zidovudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Protease inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Abacavir sulfate + lamivudine + zidovudine false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Abacavir sulfate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Abacavir- and lamivudine- and zidovudine-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Zidovudine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Abacavir- and lamivudine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Lamivudine- and zidovudine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Lamivudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 150 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Lamivudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Lamivudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 150 false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zidovudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Zidovudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Zidovudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Abacavir- and lamivudine- and zidovudine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient Zidovudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient Lamivudine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient Abacavir (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Is a Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Plays role Antiretroviral therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start